Featured Stories
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Read More
Medis Received the Platinum Creditworthiness Certificate of Excellence for 2020
The Bisnode Analytics Services has ranked Medis among the 1.5% of the most successful, reliable, credible and low-risk companies for cooperation with other...
Read More
A new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Read More
Together With the COVID-19 Pandemic, the World is also Facing a Stress Pandemic
With Dr Jukić we discussed the current situation, the pandemic, and its influence on mental disorders, as well as his new research work.
Read More
Applications for the 2020 International Medis Awards Are Open!
Already for the seventh consecutive year we are opening the gates of the contest for outstanding achievements in medicine and pharmacy – the International Medis...
Read More
Periodontitis – A War on Teeth and Immune System
The known disease of periodontal tissue does not only cause loss of teeth, but impacts the immune system as well.
Read More